The review demonstrated that the WHO-5 has high clinimetric validity , can be used as an outcome measure balancing the wanted and unwanted effects of treatments , is a sensitive and specific screening tool for depression and its applicability across study fields is very high .
Conclusions : The WHO-5 is a short question naire consisting of 5 simple and non-invasive questions , which tap into the subjective well-being of the respondents .
The scale has adequate validity both as a screening tool for depression and as an outcome measure in clinical trials and has been applied successfully across a wide range of study fields
Background : The 5-item World Health Organization Well-Being Index ( WHO-5 ) is among the most widely used question naires assessing subjective psychological well-being .
Since its first publication in 1998 , the WHO-5 has been translated into more than 30 language s and has been used in research studies all over the world .
We now provide a systematic review of the literature on the WHO-5 .
Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes
OBJECTIVE To investigate the effects of continuous intraperitoneal insulin infusion ( CIPII ) compared with subcutaneous insulin on health-related quality of life ( HRQOL ) and treatment satisfaction , and to perform a cost analysis in type 1 diabetes . RESEARCH DESIGN AND METHODS We used an open-label , prospect i ve , crossover , r and omized , 16-month study ( N = 24 ) .  HRQOL and patient satisfaction were assessed with question naires ( the 36-item short-form health survey [ SF-36 ] , the World Health Organization-Five Well-Being Index [ WHO-5 ] , and the Diabetes Treatment Satisfaction Question naire [ DTSQ ] ) . Direct costs  of CIPII and continuous subcutaneous insulin infusion ( CSII ) were compared . RESULTS Question naire scores were higher with CIPII than with subcutaneous therapy . Yearly direct pump- and procedure-associated costs  for CIPII were estimated at € 10,910 compared with € 4,810 for CSII . CONCLUSIONS Apart from improving glycemic control , CIPII improved HRQOL and treatment satisfaction compared with subcutaneous insulin . Direct pump- and procedure-associated costs are considerably higher for CIPII , however
The review demonstrated that the WHO-5 has high clinimetric validity , can be used as an outcome measure balancing the wanted and unwanted effects of treatments , is a sensitive and specific screening tool for depression and its applicability across study fields is very high .
Conclusions : The WHO-5 is a short question naire consisting of 5 simple and non-invasive questions , which tap into the subjective well-being of the respondents .
The scale has adequate validity both as a screening tool for depression and as an outcome measure in clinical trials and has been applied successfully across a wide range of study fields
Background : The 5-item World Health Organization Well-Being Index ( WHO-5 ) is among the most widely used question naires assessing subjective psychological well-being .
Since its first publication in 1998 , the WHO-5 has been translated into more than 30 language s and has been used in research studies all over the world .
We now provide a systematic review of the literature on the WHO-5 .